Docoh
Loading...

PCSA Processa Pharmaceuticals

Filed: 25 Sep 20, 8:00am

 

Processa Pharmaceuticals, Inc.

 

7380 Coca Cola Drive, Suite 106,

Hanover, Maryland 21076

 

September 25, 2020

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attention: Mr. Tim Buchmiller

 

 Re:Processa Pharmaceuticals, Inc.
  Registration Statement on Form S-1 (Registration No. 333-235511)

 

Ladies and Gentlemen:

 

Reference is made to our letter to you dated September 22, 2020 (the “Acceleration Request”) to request that the Processa Pharmaceuticals, Inc. Registration Statement on Form S-1 (Registration No. 333-235511) be declared effective at 4:30 p.m., Eastern time, on September 24, 2020, or as soon as practicable thereafter. We now respectfully withdraw the Acceleration Request.

 

The Registrant respectfully requests that you contact Michael Kirwan of Foley & Lardner LLP by telephone call to (904) 633-8913 with any questions or requests for additional information.

 

 Very truly yours,
  
 Processa Pharmaceuticals, Inc.
   
 By:/s/ David Young
  David Young, Pharm.D., Ph.D.
  Chief Executive Officer